Bank of New York Mellon
SGP

Bank of New York Mellon’s SpyGlass Pharma SGP Stock Holding History

Bank of New York Mellon’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
+23,944
New +$519K ﹤0.01% 3721

Other funds holding SGP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Bank of New York Mellon's SGP Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 23,944 shares worth $533K. The stake represents ﹤0.01% of the portfolio and ranks #3721 among its holdings.

14 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • Bank of New York Mellon held 23,944 shares of SpyGlass Pharma worth $533K as of Q2 2026.
  • SpyGlass Pharma was a new Bank of New York Mellon position in Q2 2026.
  • SpyGlass Pharma made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3721 holding.
  • 14 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.